NCT04508179 - A Phase 1 SAD and MAD Study of the Safety, Tolerability and PK of 7HP349 in Normal Healthy Male Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 28, 2020

Primary Completion Date

October 25, 2021

Study Completion Date

October 25, 2021

Conditions

Solid Tumor

Interventions

DRUG

7HP349 Single Ascending Dose

Part A: 7HP349 Capsules, Single Ascending Dose (SAD)

DRUG

7HP349 Multiple Ascending Dose

Part B: 7HP349 Capsules, Multiple Ascending Dose (MAD)

DRUG

Placebo Single Ascending Dose

Part A: Placebo Capsules, Single Ascending Dose (SAD)

DRUG

Placebo Multiple Ascending Dose

Part B: Placebo Capsules, Multiple Ascending Dose (MAD)

DRUG

7HP349 Food Effect

Part C: 7HP349 Capsules, Food Effect

Trial Locations (1)

Frontage Clinical Services Inc., Secaucus